V. Ashutosh Rao

Jun 21, 2023 | nature.com | Emma Scott |Rodney Moore Jr |Richard Pazdur |V. Ashutosh Rao |Julie Schneider

AbstractThe cancer treatment landscape has changed dramatically since the turn of the century, resulting in substantial improvements in outcomes for patients. This Review summarizes trends in the approval of oncology therapeutic products by the United States Food and Drug Administration (FDA) from January 2000 to October 2022, based on a categorization of these products by their mechanism of action and primary target.